Novartis Marketing Settlement With DoJ Ends Only Some Investigations
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm will pay $185 million criminal fine for practices related to Trileptal, but has yet to settle on civil penalties relating to its marketing practices.